High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers

By afschroeder • August 9, 2025

Ennin E, Mallepally N, Ali M, Shojaie L, Dewberry S, Trieu M, Torres ETR, Zhou K, Kahn J, Dodge JL, Dara L. High Grade Hepatotoxicity From Dual Checkpoint Inhibitors Is More Common in Hepatocellular Carcinoma Than Other Cancers. Liver Int. 2025 Sep;45(9):e70255. doi: 10.1111/liv.70255. PMID: 40778804.

Tags: CTLA‐4, Digestive Diseases, Fellow, ILICI, immune‐related adverse events, immunotherapy, liver injury, PD‐1, Publications

Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction

Veraza DI, Waseem MR, Venezia J, Montero AM, Jones S, Kadariya J, Gupta A, Xu H, Shin A. Perceived Utility of Cognitive Behavioral Therapy in[...]

Evaluating the Impact of Different Biliary Stents for Bile Leak Following Fenestrated Cholecystectomy: A Retrospective Multicenter Study

Turner R, Mendez D, Karna R, Liu PH, Issa D, Bilal M, Shah S, Ellis D, Tielleman T. Evaluating the Impact of Different Biliary Stents[...]

Sensory Over-Responsivity in Autism: A Bidirectional Brain-Gut-Microbiome Model

Ringold SM, Cermak SA, Labus JS, Mayer EA, Aziz-Zadeh L. Sensory Over-Responsivity in Autism: A Bidirectional Brain-Gut-Microbiome Model. J Autism Dev Disord. 2026 Mar 4.[...]